Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients
Authors:
- Soumana C NasserSNSoumana C Nasser
- Jeanette G NassifJNJeanette G Nassif
- Hani I DimassiHDHani I Dimassi
Open Access
- 1 January 2010
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 16 (8) , 982-6
Abstract
AIM: To assess the appropriateness of the indication and route of administration of proton-pump-inhibitors (PPIs) and their associated cost impact. METHODS: Data collection was performed prospectively during a 6-mo period on 340 patients who received omeprazole intravenously during their hospital stay in non-intensive care floors. Updated guidelines were used to assess the appropriateness of the indication and route of administration. RESULTS: Complete data collection was available for 286 patients which were used to assess intravenous (IV) PPIs utilization. Around 88% of patients were receiving PPIs for claimed stress ulcer prophylaxis (SUP) indication; of which, only 17% met the guideline criteria for SUP indication, 14% met the criteria for non-steroidal-anti-inflammatory drugs-induced ulcer prophylaxis, while the remaining 69% were identified as having an unjustified indication for PPI use. The initiation of IV PPIs was appropriate in 55% of patients. Half of these patients were candidates for switching to the oral dosage form during their hospitalization, while only 36.7% of these patients were actually switched. The inappropriate initiation of PPIs via the IV route was more likely to take place on the medical floor than the surgical floor (53% vs 36%, P = 0.003). The cost analysis associated with the appropriateness of the indication for PPI use as well as the route of administration of PPI revealed a possible saving of up to $17 732.5 and $14 571, respectively. CONCLUSION: This study highlights the over-utilization of IV PPIs in non-intensive care unit patients. Restriction of IV PPI use for justified indications and route of administration is recommended.Keywords
This publication has 16 references indexed in Scilit:
- Use of Intravenous Proton-Pump Inhibitors in a Teaching Hospital PracticeDigestive Diseases and Sciences, 2008
- Intravenous proton pump inhibitor use in hospital practiceEuropean Journal of Gastroenterology & Hepatology, 2007
- Predictors of inappropriate utilization of intravenous proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 2006
- Primer: managing NSAID-induced ulcer complications—balancing gastrointestinal and cardiovascular risksNature Clinical Practice Gastroenterology & Hepatology, 2006
- Hospital‐acquired gastrointestinal bleeding outside the critical care unit: Risk factors, role of acid suppression, and endoscopy findingsJournal of Hospital Medicine, 2006
- Inappropriate Use of Intravenous Pantoprazole: Extent of the Problem and Successful SolutionsClinical Gastroenterology and Hepatology, 2005
- Use of Intravenous Proton Pump Inhibitors in Community Practice: An Explanation for the Shortage?American Journal of Gastroenterology, 2004
- Cost‐effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleedingAlimentary Pharmacology & Therapeutics, 2003
- Alternative dosing for PPI therapy: rationale and options.2003
- ASHP Therapeutic Guidelines on Stress Ulcer ProphylaxisAmerican Journal of Health-System Pharmacy, 1999